ArticleGlobal & regional health technology assessment

Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections.

Matteo Scortichini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.